Treating Gout or Hyperuricemia in CKD Patients

Abdul Abdellatif

Analysis of Gout Remission Definitions in a Randomized Controlled Tr…

The Journal of Rheumatology

E. Silverman, D. Tabi-Amponsah, N. Dalbeth

Gout Management Mistakes: Why Are Gout Patients Not Being Referred t…

RheumNow

J. Cush

Treating to Target in Chronic Gout

Cleveland Clinic Rheumatology

P. Lipsky

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

Inflammatory Arthritis: What Is It?

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

USSONAR Rheumatology Ultrasound Case Series Featuring Dr. Phil Chu

USSONAR

Update in Rheumatology 2023 (Gout, JAK safety in RA, Dermatomyositis…

John Tesser

Clinical Implications of DISSOLVE I Phase 3, Double-Blind, Placebo-C…

EULAR® 2024 Insights

A. Kivitz

2023 Rheumatology Year in Review

RheumNow

J. Cush

Rheumatology for the Orthopedist (in 10 min)

FORE 2021 Atlanta Orthopaedic Symposium

K. O'Harra Browne Weselman

Clinical Benefits of Pegloticase

Guillermo Valenzuela

SAPHO

Cleveland Clinic Medical Specialty Institute

A. Brown

Skin Manifestations of Rheumatologic Diseases

Keck School of Medicine of USC

B. Ngo

Rheumatology for the Hand Orthopedist

NYU Langone Orthopedic Webinar Series

Y. Ali

Athletic Rheumatism College Wrestler with Knee Pain & Athletic Rheum…

Cleveland Clinic Rheumatology

A. Elghawy

ACR 2020 Highlights: Gout Therapies for Urate Lowering and Phase 1 T…

RheumNow

M. Pillinger

Updates in Management of Acute and Recurrent Gout

Icahn School of Medicine at Mount Sinai

B. Moghaddam

New Meets Old- Biologics in the World of Gout

Cleveland Clinic Medical Specialty Institute

B. Mandell

Vital Info on Autoimmune Disease

RheumNow

J. Cush